Diagnostic Imaging's A Look Ahead: March 8, 2021, to March 12, 2021

Whitney J. Palmer

Here's what to expect this week on Diagnostic Imaging.

In this week’s preview, here are some highlights of what you can expect to see coming soon:

A flurry of studies have been published in recent months about the efficacy and utilization of low-dose CT (LDCT) for lung cancer screening – these articles point to whether the exam actually works as proclaimed and how much impact it actually is having. The consensus is that the screening test is effective, but that there is still a lot of room for improvement in screening patients who could significantly benefit. This week, more data and guidance are coming. Keep your eyes open for an article in the coming days about who should be screened and when.

For more LDCT lung cancer screening coverage, click here.

For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.

The value of MRI as a sensitive diagnostic tool is already widely known, and the modality continues to advance. This week, Editorial Board member Eliot Siegel, M.D., radiology professor and vice chair at the University of Maryland School of Medicine, takes a deep dive into what could be the next frontier for MRI – very low field strength. He explores the drivers behind the expansion of this advancement and what makes it effective. Look for his in-depth analysis later this week.

For more coverage of low-field strength MRI, click here.

Significant weight loss can be alarming for a patient, especially if it is unintended and the reason behind it is unclear. In an article published in Emergency Radiology, researchers reveal that CT can be useful in pinpointing the cause of an unexpected, rapid loss of pounds. A more detailed explanation of their findings will be published later this week.

For additional coverage on weight loss, click here.